Merck Hikes Forecast as Keytruda Tops $3 Billion for Quarter

(Bloomberg) -- Merck & Co. raised its full-year sales and profit forecast for the third time in a row on Tuesday, after the drugmaker’s market-leading cancer drug Keytruda handily beat an average o...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.